IncFact
Company Profiles: Revenue, Growth, Competition

TARVEDA THERAPEUTICS Revenue, Growth & Competitor Profile

DBA BLEND THERAPEUTICS
Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Fast Growing
Fastest Growing
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Tarveda Therapeutics

Access the complete profile.

Tarveda Therapeutics Fast Facts

Revenue$1 - $10 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry54138 Testing Laboratories
Additional NAICS Codes541711 Research & Development in Biotechnology
Address134 Coolidge Ave.
Watertown, MA 02472

www.blendtx.com
Note: Revenues for privately held companies are statistical evaluations.


Tarveda Therapeutics's annual revenues are $1-$10 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Testing Laboratories industry.


Tarveda Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Tarveda Therapeutics Annual Revenue and Growth Rate

Tarveda Therapeutics Revenue Est.
($ Million)
Growth Rate (%)# Employees
2018 Details in Premium Report
2017
2016
2015
2014
2013
2012


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Tarveda Therapeutics's revenues are gauged from an analysis of company filings.



Investor Activity

Tarveda Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
December 26, 2019 13 100%$14 MM
Complete list of funding rounds and total amounts in the Company Report




Tarveda Therapeutics's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Tarveda Therapeutics Revenue (Sales) Tarveda Therapeutics Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Tarveda Therapeutics is developing and marketing. Tarveda Therapeutics doesn't have any recent trademark applications, indicating Tarveda Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
TARVEDA THERAPEUTICS
Pharmaceutical research and development
01/13/2016
PENTARIN
Biochemicals for in vitro and in vivo scientific research, medical research and scientific use; Biochemicals, namely, conjugates for in vitro and in vivo scientific research, medical research and scientific use; Biochemicals, namely, conjugates for use in the manufacture of pharmaceuticals for treating hyperproliferative diseases and disorders
11/18/2014
BLEND THERAPEUTICS
Pharmaceuticals, namely, antineoplastics, anti-inflammatories, anti-infectives, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals, cardiovascular pharmaceuticals, dermatological pharmaceutical products, inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders, pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, pharmaceutical preparations for the treatment and prevention of diseases and disorders of the auto-immune system, the metabolic system, the musculo-skeletal system and the genitourinary system, pharmaceutical preparations for use in hematology and in tissue and organ transplantation, pharmaceutical preparations for the treatment of eye diseases and conditions, pharmaceutical preparations for the treatment of heart rhythm disorders, pharmaceutical preparations for the treatment of immune system related diseases and disorders, pharmaceutical preparations for the treatment of kidney diseases, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for treating hypertension, pharmaceutical preparations for treating skin disorders, pharmaceutical preparations for use in dermatology, pharmaceutical preparations for use in urology, pharmaceutical products for ophthalmological use, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical products for the treatment of bone diseases, pharmaceutical products for treating respiratory diseases, pharmaceutical products for treating respiratory diseases and asthma, pharmaceutical preparations for the treatment of sleep disorders and neurological disorders; nano-particles, namely, those composed of polymers, therapeutics, or excipients used for medical diagnostic purposes and for the treatment of cancer, inflammation, cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, infectious diseases, diabetes, impotence, obesity, arthritis and autoimmune disorders; pharmaceuticals and medicines containing nano-particles, for use for the prevention and/or treatment of cancer, cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, infectious diseases, diabetes, impotence, obesity, arthritis and autoimmune disorders, and for use as drug delivery agents consisting of substances that facilitate delivery of a wide range of pharmaceuticals allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals for the treatment of cancer, cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, infectious diseases, diabetes, impotence, obesity, arthritis and autoimmune disorders; vaccines incorporating nano-particles
09/15/2014

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Tarveda Therapeutics grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Tarveda Therapeutics is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Testing Laboratories

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Tarveda Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Tarveda Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
PACE ANALYTICAL SERVICESMinneapolis, MN100 
ULNorthbrook, IL41 
INTERTEK USAHouston, TX11 
EUROFINS SCIENTIFICDes Moines, IA10 
OCTAPHARMA PLASMACharlotte, NC4 
NTS TECHNICAL SYSTEMSSanta Clarita, CA3 
TESTAMERICA LABORATORIESNorth Canton, OH3 
STERLING INFOSYSTEMSNew York, NY2 
EAGSanta Clara, CA1 




Nearby Competitors

These companies are similar in business line and location to Tarveda Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
VANASSE HANGEN BRUSTLINWatertown, MA100 
SIMPSON GUMPERTZ & HEGERWaltham, MA40 
SASAKI ASSOCIATESWatertown, MA20 
AHA CONSULTING ENGINEERSLexington, MA8 
WITRICITYWatertown, MA3 
DRUMMEY ROSANE ANDERSONWaltham, MA2 




Future Competition: Tarveda Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Tarveda Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Tarveda Therapeutics Competitors